In the case of a product used for an “acute” condition, should incidence of < 200,000 be used instead of prevalence?

If a disease is an acute condition (i.e., less than one year duration) incidence may be used as an estimate of the population. However, if the disease is a relapsing/remitting disease where each episode is acute in duration, a prevalence estimate may still be required.